Substituted 2,3-dihydroimidazo[1,2-c]quinazoline derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis

• 收藏
• 分享

专利权人:

Bayer Intellectual Property GMBH

发明人:

Hentemann Martin,Wood Jill,Scott William,Michels Martin,Campbell Ann-Marie,Bullion Ann-Marie,Rowley Bruce R.,Redman Aniko

申请号：

US201715398916

公开号：

USRE46856(E1)

申请日:

2017.01.05

申请国别(地区):

美国

年份:

2018

代理人:

White & Case LLP

摘要：

This invention relates to novel 2,3-dihydroimidazo[1,2-c]quinazoline compounds, pharmaceutical compositions containing such compounds and the use of those compounds or compositions for phosphotidylinositol-3-kinase (PI3K) inhibition and treating diseases associated with phosphotidylinositol-3-kinase (PI3K) activity, in particular treating hyperproliferative and/or angiogenesis disorders, as a sole agent or in combination with other active ingredients.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/